Stuart Essig insider trades: Integra Lifesciences Holdings (IART) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stuart reports to the SEC
and 3 more companies
Open-market buys and sales
65 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 23, 2024 | IART | ↑ Buy | 52,641 | $28.49 | $1.5M | Direct | May 24, 2024 (1d) |
| Mar 18, 2021 | IART | ↓ Sell | 214,553 | $68.14 | $14.6M | By Trust | Mar 22, 2021 (4d) |
| May 28, 2020 | IART | ↓ Sell | 147,912 | $52.14 | $7.7M | Direct | May 28, 2020 (0d) |
| May 12, 2020 | IART | ↓ Sell | 2,087 | $52.07 | $109K | Direct | May 14, 2020 (2d) |
| Feb 15, 2019 | SPNE | ↓ Sell10b5-1 | 16,976 | $16.09 | $273K | By Foundation | Feb 15, 2019 (0d) |
| Feb 15, 2019 | SPNE | ↓ Sell10b5-1 | 16,976 | $16.09 | $273K | By Family Trust | Feb 15, 2019 (0d) |
| Feb 13, 2019 | SPNE | ↓ Sell10b5-1 | 15,574 | $16.09 | $251K | By Family Trust | Feb 13, 2019 (0d) |
| Feb 13, 2019 | SPNE | ↓ Sell10b5-1 | 15,574 | $16.09 | $251K | By Foundation | Feb 13, 2019 (0d) |
| Aug 2, 2018 | SPNE | ↓ Sell | 43,496 | $14.00 | $609K | Direct | Aug 3, 2018 (1d) |
| Jul 24, 2018 | IART | ↓ Sell | 69,871 | $63.54 | $4.4M | Direct | Jul 25, 2018 (1d) |
| Jul 17, 2018 | IART | ↓ Sell | 31,353 | $63.50 | $2.0M | Direct | Jul 19, 2018 (2d) |
| Jul 10, 2018 | IART | ↓ Sell | 159,752 | $64.01 | $10.2M | Direct | Jul 11, 2018 (1d) |
| Jan 3, 2018 | DYNT | ↑ Buy | 22,865 | $2.77 | $63K | Direct | Jan 4, 2018 (1d) |
| Jan 3, 2018 | DYNT | ↑ Buy | 4,590 | $2.77 | $13K | Family Trust | Jan 4, 2018 (1d) |
| Nov 30, 2017 | DYNT | ↑ Buy | 398,010 | $2.50 | $995K | Direct | Dec 1, 2017 (1d) |
| May 25, 2017 | IART | ↓ Sell | 135,000 | $49.90 | $6.7M | Direct | May 26, 2017 (1d) |
| May 23, 2017 | IART | ↓ Sell | 140,000 | $48.01 | $6.7M | Direct | May 24, 2017 (1d) |
| Mar 13, 2017 | SPNE | ↑ Buy | 50,000 | $6.67 | $334K | Direct | Mar 14, 2017 (1d) |
| Apr 27, 2016 | IART | ↓ Sell | 104,390 | $70.15 | $7.3M | Direct | Apr 28, 2016 (1d) |
| Apr 6, 2016 | IART | ↓ Sell | 21,100 | $66.19 | $1.4M | Direct | Apr 7, 2016 (1d) |
| Apr 5, 2016 | IART | ↓ Sell | 83,290 | $66.68 | $5.6M | Direct | Apr 6, 2016 (1d) |
| Aug 20, 2015 | SPNE | ↑ Buy | 65,100 | $15.33 | $998K | By Trust | Aug 20, 2015 (0d) |
| May 7, 2015 | IART | ↓ Sell | 75,000 | $64.32 | $4.8M | Direct | May 8, 2015 (1d) |
| May 6, 2015 | IART | ↓ Sell | 125,000 | $64.83 | $8.1M | Direct | May 7, 2015 (1d) |
| Apr 24, 2015 | STJ | ↓ Sell | 7,750 | $73.85 | $572K | Direct | Apr 28, 2015 (4d) |
| Feb 20, 2015 | OMI | ↑ Buy | 14,489 | $34.51 | $500K | Direct | Feb 23, 2015 (3d) |
| Oct 29, 2014 | IART | ↓ Sell | 52,902 | $49.50 | $2.6M | Direct | Oct 31, 2014 (2d) |
| Oct 28, 2014 | IART | ↓ Sell | 147,098 | $49.58 | $7.3M | Direct | Oct 29, 2014 (1d) |
| Jul 30, 2014 | IART | ↓ Sell | 50,800 | $47.76 | $2.4M | Direct | Jul 31, 2014 (1d) |
| Jul 23, 2014 | IART | ↓ Sell | 27,819 | $47.80 | $1.3M | Direct | Jul 24, 2014 (1d) |
| Jun 23, 2014 | IART | ↓ Sell | 21,381 | $47.76 | $1.0M | Direct | Jun 24, 2014 (1d) |
| Jun 6, 2014 | IART | ↓ Sell | 17,900 | $46.34 | $829K | Direct | Jun 10, 2014 (4d) |
| Apr 3, 2014 | IART | ↓ Sell | 6,344 | $46.01 | $292K | Direct | Apr 7, 2014 (4d) |
| Apr 2, 2014 | IART | ↓ Sell | 76,177 | $46.05 | $3.5M | Direct | Apr 3, 2014 (1d) |
| Mar 31, 2014 | IART | ↓ Sell | 17,479 | $46.05 | $805K | Direct | Apr 1, 2014 (1d) |
| Jan 16, 2014 | IART | ↓ Sell | 8,037 | $49.59 | $399K | Direct | Jan 21, 2014 (5d) |
| Jan 14, 2014 | IART | ↓ Sell | 10,600 | $49.50 | $525K | Direct | Jan 16, 2014 (2d) |
| Jan 13, 2014 | IART | ↓ Sell | 99,032 | $49.51 | $4.9M | Direct | Jan 14, 2014 (1d) |
| Jan 9, 2014 | IART | ↓ Sell | 114,431 | $49.58 | $5.7M | Direct | Jan 10, 2014 (1d) |
| Jul 29, 2013 | STJ | ↓ Sell | 5,600 | $52.19 | $292K | Direct | Jul 31, 2013 (2d) |
| Apr 26, 2013 | STJ | ↓ Sell | 5,600 | $41.30 | $231K | Direct | Apr 30, 2013 (4d) |
| May 2, 2012 | STJ | ↓ Sell | 8,000 | $38.70 | $310K | Direct | May 4, 2012 (2d) |
| Apr 25, 2011 | STJ | ↓ Sell | 8,000 | $51.75 | $414K | Direct | Apr 27, 2011 (2d) |
| Mar 8, 2011 | IART | ↓ Sell | 74,900 | $49.33 | $3.7M | Direct | Mar 9, 2011 (1d) |
| Mar 7, 2011 | IART | ↓ Sell | 125,100 | $49.69 | $6.2M | Direct | Mar 8, 2011 (1d) |
| Dec 3, 2010 | IART | ↓ Sell | 100,000 | $45.20 | $4.5M | Direct | Dec 3, 2010 (0d) |
| Nov 3, 2010 | IART | ↓ Sell | 100,000 | $43.03 | $4.3M | Direct | Nov 4, 2010 (1d) |
| Apr 23, 2010 | STJ | ↓ Sell | 16,000 | $41.10 | $658K | Direct | Apr 27, 2010 (4d) |
| Mar 12, 2010 | IART | ↓ Sell | 72,400 | $41.77 | $3.0M | Direct | Mar 16, 2010 (4d) |
| Mar 11, 2010 | IART | ↓ Sell | 36,000 | $42.11 | $1.5M | Direct | Mar 12, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Stuart Essig's insider trades
Stuart Essig is President and CEO at Integra Lifesciences Holdings (IART). Since Jan 3, 2006, Stuart has reported 8 open-market purchases worth $4.8M and 57 sales worth $174.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
4 sales (1% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (131 filings), option exercises (44 filings), other transactions (24 filings), shares withheld for taxes (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IART insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.